КЛИНИКО-ЛАБОРАТОРНЫЕ ОСОБЕННОСТИ ИММУННОГО ОТВЕТА У ДЕТЕЙ С ИНФЕКЦИЕЙ COVID-19
Аннотация
В статье представлены результаты анализа клинико-морфологической характеристики и ряда показателей периферической крови у детей с новой коронавирусной инфекцией.
Цель исследования – дать клинико-лабораторную характеристику иммунного ответа у детей с новой коронавирусной инфекцией.
Материалы и методы. Обследовано 102 детей с новой коронавирусной инфекцией. Оценка показателей периферической крови и субпопуляций лимфоцитов у детей трех возрастных групп 0-4 лет, 5-9 лет и 10-14 лет.
Результаты. У детей с новой коронавирусной инфекцией наблюдается дисбаланс гранулоцитарного и лимфоцитарного звена, наиболее выраженный для детей младшего (0-4 года) и среднего (5-9 лет) возрастной групп. Общая тенденция изменений характеризуется повышением лимфоцитов и гранулоцитов в начале заболевания и снижение через 2 недели. Коэффициент соотношения нейтрофилов к лимфоцитам демонстрирует преобладание нейтрофилов.
Заключение. Наше исследование продемонстрировало, что при острой фазе вирусной инфекции COVID-19 у детей происходит увеличение содержания нейтрофилов, относительно содержания лимфоцитов. При анализе показателей субпопуляций лимфоцитов у детей было установлено снижение Т-цитотоксических лимфоцитов (CD3+CD8+), NK-лимфоцитов (CD16+CD56+) и В-лимфоцитов (CD19+) относительно нормы. Исследования дают важные клинические данные во время продолжающейся пандемии.
Скачивания
Литература
Список литературы
Губенко Н.С. Связь показателей общего анализа крови с тяжестью течения COVID-19 у госпитализированных пациентов / Н.С. Губенко, А.А. Будко, А.Г. Плисюк // Южно-Российский журнал терапевтической практики. 2021. Т. 2(1). С. 90-101. https://doi.org/10.21886/2712-8156-2021-2-1-90-101
Заболевание COVID-19 у детей и подростков. Научная справка 29 сентября 2021 г. https://apps.who.int/iris/bitstream/handle/10665/345575/WHO-2019-nCoV-Sci-Brief-Children-and-adolescents-2021.1-rus.pdf (дата обращения: 15.03.2023)
Клинико-лабораторная характеристика тяжелых форм новой коронавирусной инфекции / Ж. Б. Понежева, А. А. Гришаева, Л. К. Алимова, и др. // Терапия. 2022. №3. С. 7-13. https://dx.doi.org/10.18565/therapy.2022.3.7-13
Сухомлинова И. М. Клинико-лабораторные и инструментальные предикторы эффективности противовоспалительной терапии при COVID-19 / И. М. Сухомлинова, И. Г. Бакулин, М. Ю. Кабанов // Вестник Северо-Западного государственного медицинского университета им. И.И. Мечникова. 2022. Т. 14, № 3. C. 53-60. https://doi.org/10.17816/mechnikov109536
Aberdein J.D., Cole J., Bewley M.A., Marriott H.M., Dockrell D.H. Alveolar Macrophages in Pulmonary Host Defence the Unrecognized Role of Apoptosis as a Mechanism of Intracellular Bacterial Killing // Clin. Exp. Immunol. 2013. Vol. 174. P. 193–202.
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19 / A. Thiriard, B. Meyer, C.S. Eberhardt, et al. // Front. Immunol. 2023. Vol. 14. P. 1107156. https://doi.org/10.3389/fimmu.2023.1107156
Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers / V. Seery, S.C. Raiden, S.C. Algieri, at al. // EBioMedicine. 2021. Vol. 67. P. 103357.
Children and young people remain at low risk of COVID-19 mortality / S. B. Sunil, B. Jayshree, O. Bayanne, B. Raj. 2021. https://doi.org/10.1016/ S2352-4642(21)00066-3
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China / C. Huang, Y. Wang, X. Li et al. // Lancet. 2020. Vol. 395. P. 497-506. https://doi.org/10.1016/S0140-6736 (20)30183-5
COVID-19 Disease in Under-5 Children: Current Status and Strategies for Prevention including Vaccination / A. Pillai, A. Nayak, D. Tiwari, at al. // Vaccines. 2023. Vol. 11. P. 693. https://doi.org/10.3390/vaccines11030693
COVID-19 in 7780 pediatric patients: a systematic review / A. Hoang, K. Chorath, M. Moreira, et al. // E. Clinical. Medicine. 2020. Vol. 24(100433). https://doi.org/10.1016/j.eclinm.2020.100433
COVID-19 in children and the dynamics of infection in families / K.M. Posfay-Barbe, N. Wagner, M. Gauthey, et al. // Pediatrics. 2020. Vol. 146 (2). e20201576. https://doi.org/10.1542/peds.2020-1576
COVID-19 in children treated with immunosuppressive medication for kidney diseases / M. Marlais, T. Wlodkowski, S. Al-Akash, et al. // Arch. Dis. Child. 2021. Vol. 106. P. 798–801.
COVID-19 in children. II: Pathogenesis, disease spectrum and management / A.R. Howard-Jones, D.P. Burgner, N.W. Crawford, et al. // Journal of Paediatrics and Child Health. 2022. Vol. 58. P. 46–53.
Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. / W. Liu, Q. Zhang, J. Chen, et al. // N. Engl. J. Med. 2020. Vol. 382(14). P. 1370-1371. https://doi.org/10.1056/NEJMc2003717
Effects of Coronavirus Disease 2019 (COVID-19) on Peripheral Blood Lymphocytes and Their Subsets in Children: Imbalanced CD4+/CD8+ T Cell Ratio and Disease Severity / S. Mahmoudi, B. Yaghmaei, M. Sharifzadeh Ekbatani, et al. // Front. Pediatr. 2021. Vol. 9, 643299. P. 1-7. https://doi.org/10.3389/fped.2021.643299
Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients / J. L. Casado, E. Moraga, P. Vizcarra, et al. // Viruses. 2022. Vol. 14 (1). P. 46. https://doi.org/10.3390/v14010046
Hematological parameters and peripheral blood morphologic abnormalities in children with COVID-19 / N. Yarali, Y. M. Akcabelen, Y. Unal, A. Ö. Parlakay // Authorea. 2020. https://doi.org/10.22541/au.159069193.34265275
https://covid.cdc.gov/covid-data-tracker/#pediatric-data (дата обращения: 28.10.2022)
Kuklina E. M. T Lymphocytes as Targets for SARS-CoV-2 // Biokhimiya. 2022. Vol. 87, No. 6. P. 780-793. https://doi.org/10.1134/s0006297922060086
Low-avidity CD4(+) T cell responses to SARS-CoV-2 in unexposed individuals and humans with severe COVID-19 / P. Bacher, E. Rosati, D. Esser et al. // Immunity. 2020. Vol. 53. P. 1258–1271. https://doi.org/10.1016/j.immuni.2020.11.016
Lymphocyte Subsets in Mild COVID-19 Pediatric Patients / M. Argun, D. B. İnan, H. T. Hörmet Öz, et al. // Turk. Arch. Pediatr. 2022. Vol. 57(2). P. 210-215. https://doi.org/10.5152/TurkArchPediatr.2022.21245
Merad M. Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages / M. Merad, J.C. Martin // Nat. Rev. Immunol. 2020. Vol. 20(6). P. 355–362. https://doi.org/10.1038/s41577-020-0331-4
Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis / A. Schreiber, A. Rousselle, J.U. Becker, et al. // Proc. Natl. Acad. Sci. USA. 2017. Vol. 114(45). E9618-E9625. https://doi.org/10.1073/pnas.1708247114
Neutrophil diversity in health and disease / C. Silvestre-Roig, Z.G. Fridlender, M. Glogauer, P. Scapini // Trends Immunol. 2019. Vol. 40(7). P. 565–583. https://doi.org/10.1016/j.it.2019.04.012
Neutrophil Extracellular Traps in COVID-19 / Y. Zuo, S. Yalavarthi, H. Shi, et al. // JCI Insight. 2020. Vol. 5. e13899. https://doi.org/10.1172/jci.insight.138999
Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population / F. Imtiaz, K. Shafique, S. Mirza, et al. // International Archives of Medicine. 2012. Vol. 5(1). P. 2–8. https://doi.org/10.1186/1755-7682-5-2
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage / J. Liu, Y. Liu, P. Xiang, et al. // Journal of Translational Medicine. 2020. Vol. 18(1). P. 206–218. https://doi.org/10.1186/s12967-020-02374-0
New Insights into the Immune Molecular Regulation of the Pathogenesis of Acute Respiratory Distress Syndrome / C.-Y. Yang, C.-S. Chen, G.-T. Yiang, et al. // Int. J. Mol. Sci. 2018. Vol. 19. P. 588. https://doi.org/10.3390/ijms19020588
Perinatal Inflammation Influences but Does Not Arrest Rapid Immune Development in Preterm Babies / S. Kamdar, R. Hutchinson, A. Laing, et al. // Nat. Commun. 2020. Vol. 11. P. 1284. https://doi.org/10.1038/s41467-020-14923-8
Robaina-Castellanos G.R. Congenital and Intrapartum SARS-CoV-2 Infection in Neonates: Hypotheses, Evidence and Perspectives / G.R. Robaina-Castellanos, S. de la Caridad Riesgo-Rodriguez // MEDICC Rev. 2021. Vol. 23. P. 72–83. https://doi.org/10.37757/mr2021.v23.n1.13
SARS-CoV-2 infection in children / X. Lu, L. Zhang, H. Du, et al. // N. Engl. J. Med. 2020. Vol. 382(17). P. 1663–1665. https://doi.org/10.1056/NEJMc2005073
Single-cell landscape of immunological responses in patients with COVID-19 / Ji.-Y. Zhang, X.-M. Wang, X. Xing, et al. // Nature Immunology. 2020. Vol. 21. P. 1107–1118. https://doi.org/10.1038/s41590-020-0762-x
Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-Analysis / R.M. Viner, O.T. Mytton, C. Bonell, et al. // JAMA Pediatr. 2021. Vol. 175. P. 143–156. https://doi.org/10.1001/jamapediatrics.2020.4573
Systems serology detects functionally distinct coronavirus antibody features in children and elderly / K.J. Selva, C.E. van de Sandt, M.M. Lemke et al. // Nat. Commun. 2021. Vol. 12. P. 2037. https://doi.org/10.1038/s41467-021-22236-7
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients / A-P. Yang, J. Liu, W. Tao, H. Li // International Immunopharmacology. 2020. Vol. 84. P. 106504. https://doi.org/10.1186/1755-7682-5-2
Validation of Predictors of Disease Severity and Outcomes in COVID-19 Patients: A Descriptive and Retrospective Study / L. Tan, X. Kang, X. Ji, et al. // Med. 2020. Vol.1 (1). P. 128–138. https://doi.org/10.1016/j.medj.2020.05.002
Ying L. Developmental Differences in Focal Adhesion Kinase Expression Modulate Pulmonary Endothelial Barrier Function in Response to Inflammation / L. Ying, C.M. Alvira, D.N. Cornfield // Am. J. Physiol.-Lung Cell. Mol. Physiol. 2018. Vol. 315. L66–L77. https://doi.org/10.1152/ajplung.00363.2017
Zimmermann P. Why Is COVID-19 Less Severe in Children? A Review of the Proposed Mechanisms Underlying the Age-Related Difference in Severity of SARS-CoV-2 Infections / P. Zimmermann, N. Curtis // Arch. Dis. Child. 2020. Vol. 106. P. 429–439. https://doi.org/10.1136/archdischild-2020-320338
References
Gubenko N.S., Budko A.A., Plisyuk A.G. Yuzhno-Rossiyskiy zhurnal terapevticheskoy praktiki, 2021, vol. 2(1), pp. 90-101. https://doi.org/10.21886/2712-8156-2021-2-1-90-101
Zabolevanie COVID-19 u detey i podrostkov. Nauchnaya spravka 29 sentyabrya 2021 [COVID-19 disease in children and adolescents. Scientific Briefing September 29, 2021]. https://apps.who.int/iris/bitstream/handle/10665/345575/WHO-2019-nCoV-Sci-Brief-Children-and-adolescents-2021.1-rus.pdf
Ponezheva Zh. B., Grishaeva A. A., Alimova L. K., et al. Terapiya, 2022, no. 3, pp. 7-13. https://dx.doi.org/10.18565/therapy.2022.3.7-13
Sukhomlinova I. M., Bakulin I. G., Kabanov M. Yu. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im. I.I. Mechnikova, 2022, vol. 14, no. 3, pp. 53-60. https://doi.org/10.17816/mechnikov109536
Aberdein J.D., Cole J., Bewley M.A., Marriott H.M., Dockrell D.H. Alveolar Macrophages in Pulmonary Host Defence the Unrecognized Role of Apoptosis as a Mechanism of Intracellular Bacterial Killing. Clin. Exp. Immunol., 2013, vol. 174, pp. 193–202.
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19 / A. Thiriard, B. Meyer, C.S. Eberhardt, et al. Front. Immunol., 2023, vol. 14, pp. 1107156. https://doi.org/10.3389/fimmu.2023.1107156
Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers / V. Seery, S.C. Raiden, S.C. Algieri, at al. EbioMedicine, 2021, vol. 67, pp. 103357.
Children and young people remain at low risk of COVID-19 mortality / S. B. Sunil, B. Jayshree, O. Bayanne, B. Raj. 2021. https://doi.org/10.1016/ S2352-4642(21)00066-3
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China / C. Huang, Y. Wang, X. Li et al. Lancet, 2020, vol. 395, pp. 497-506. https://doi.org/10.1016/S0140-6736 (20)30183-5
COVID-19 Disease in Under-5 Children: Current Status and Strategies for Prevention including Vaccination / A. Pillai, A. Nayak, D. Tiwari, at al. Vaccines, 2023, vol. 11, p. 693. https://doi.org/10.3390/vaccines11030693
COVID-19 in 7780 pediatric patients: a systematic review / A. Hoang, K. Chorath, M. Moreira, et al. E. Clinical. Medicine, 2020, vol. 24(100433). https://doi.org/10.1016/j.eclinm.2020.100433
COVID-19 in children and the dynamics of infection in families / K.M. Posfay-Barbe, N. Wagner, M. Gauthey, et al. Pediatrics, 2020, vol. 146 (2), e20201576. https://doi.org/10.1542/peds.2020-1576
COVID-19 in children treated with immunosuppressive medication for kidney diseases / M. Marlais, T. Wlodkowski, S. Al-Akash, et al. Arch. Dis. Child., 2021, vol. 106, pp. 798–801.
COVID-19 in children. II: Pathogenesis, disease spectrum and management / A.R. Howard-Jones, D.P. Burgner, N.W. Crawford, et al. Journal of Paediatrics and Child Health, 2022, vol. 58, pp. 46–53.
Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. / W. Liu, Q. Zhang, J. Chen, et al. N. Engl. J. Med., 2020, vol. 382(14), pp. 1370-1371. https://doi.org/10.1056/NEJMc2003717
Effects of Coronavirus Disease 2019 (COVID-19) on Peripheral Blood Lymphocytes and Their Subsets in Children: Imbalanced CD4+/CD8+ T Cell Ratio and Disease Severity / S. Mahmoudi, B. Yaghmaei, M. Sharifzadeh Ekbatani, et al. Front. Pediatr., 2021, vol. 9, 643299, pp. 1-7. https://doi.org/10.3389/fped.2021.643299
Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients / J. L. Casado, E. Moraga, P. Vizcarra, et al. Viruses, 2022, vol. 14 (1), pp. 46. https://doi.org/10.3390/v14010046
Hematological parameters and peripheral blood morphologic abnormalities in children with COVID-19 / N. Yarali, Y. M. Akcabelen, Y. Unal, A. Ö. Parlakay. Authorea, 2020. https://doi.org/10.22541/au.159069193.34265275
https://covid.cdc.gov/covid-data-tracker/#pediatric-data
Kuklina E. M. T Lymphocytes as Targets for SARS-CoV-2. Biokhimiya, 2022, vol. 87, no. 6, pp. 780-793. https://doi.org/10.1134/s0006297922060086
Low-avidity CD4(+) T cell responses to SARS-CoV-2 in unexposed individuals and humans with severe COVID-19 / P. Bacher, E. Rosati, D. Esser et al. Immunity, 2020, vol. 53, pp. 1258–1271. https://doi.org/10.1016/j.immuni.2020.11.016
Lymphocyte Subsets in Mild COVID-19 Pediatric Patients / M. Argun, D. B. İnan, H. T. Hörmet Öz, et al. Turk. Arch. Pediatr., 2022, vol. 57(2), pp. 210-215. https://doi.org/10.5152/TurkArchPediatr.2022.21245
Merad M. Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages / M. Merad, J.C. Martin. Nat. Rev. Immunol., 2020, vol. 20(6), pp. 355–362. https://doi.org/10.1038/s41577-020-0331-4
Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis / A. Schreiber, A. Rousselle, J.U. Becker, et al. Proc. Natl. Acad. Sci., 2017, vol. 114(45), pp. E9618-E9625. https://doi.org/10.1073/pnas.1708247114
Neutrophil diversity in health and disease / C. Silvestre-Roig, Z.G. Fridlender, M. Glogauer, P. Scapini. Trends Immunol., 2019, vol. 40(7), pp. 565–583. https://doi.org/10.1016/j.it.2019.04.012
Neutrophil Extracellular Traps in COVID-19 / Y. Zuo, S. Yalavarthi, H. Shi, et al. JCI Insight., 2020, vol. 5, e13899. https://doi.org/10.1172/jci.insight.138999
Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population / F. Imtiaz, K. Shafique, S. Mirza, et al. International Archives of Medicine, 2012, vol. 5(1), pp. 2–8. https://doi.org/10.1186/1755-7682-5-2
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage / J. Liu, Y. Liu, P. Xiang, et al. Journal of Translational Medicine, 2020, vol. 18(1), pp. 206–218. https://doi.org/10.1186/s12967-020-02374-0
New Insights into the Immune Molecular Regulation of the Pathogenesis of Acute Respiratory Distress Syndrome / C.-Y. Yang, C.-S. Chen, G.-T. Yiang, et al. Int. J. Mol. Sci., 2018, vol. 19, pp. 588. https://doi.org/10.3390/ijms19020588
Perinatal Inflammation Influences but Does Not Arrest Rapid Immune Development in Preterm Babies / S. Kamdar, R. Hutchinson, A. Laing, et al. Nat. Commun., 2020, vol. 11, pp. 1284. https://doi.org/10.1038/s41467-020-14923-8
Robaina-Castellanos G.R. Congenital and Intrapartum SARS-CoV-2 Infection in Neonates: Hypotheses, Evidence and Perspectives / G.R. Robaina-Castellanos, S. de la Caridad Riesgo-Rodriguez. MEDICC Rev., 2021, vol. 23, pp. 72–83. https://doi.org/10.37757/mr2021.v23.n1.13
SARS-CoV-2 infection in children / X. Lu, L. Zhang, H. Du, et al. N. Engl. J. Med., 2020, vol. 382(17), pp. 1663–1665. https://doi.org/10.1056/NEJMc2005073
Single-cell landscape of immunological responses in patients with COVID-19 / Ji.-Y. Zhang, X.-M. Wang, X. Xing, et al. Nature Immunology, 2020, vol. 21, pp. 1107–1118. https://doi.org/10.1038/s41590-020-0762-x
Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-Analysis / R.M. Viner, O.T. Mytton, C. Bonell, et al. JAMA Pediatr., 2021, vol. 175, pp. 143–156. https://doi.org/10.1001/jamapediatrics.2020.4573
Systems serology detects functionally distinct coronavirus antibody features in children and elderly / K.J. Selva, C.E. van de Sandt, M.M. Lemke et al. Nat. Commun., 2021, vol. 12, pp. 2037. https://doi.org/10.1038/s41467-021-22236-7
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients / A-P. Yang, J. Liu, W. Tao, H. Li. International Immunopharmacology, 2020, vol. 84, pp. 106504. https://doi.org/10.1186/1755-7682-5-2
Validation of Predictors of Disease Severity and Outcomes in COVID-19 Patients: A Descriptive and Retrospective Study / L. Tan, X. Kang, X. Ji, et al. Med., 2020, vol.1 (1), pp. 128–138. https://doi.org/10.1016/j.medj.2020.05.002
Ying L. Developmental Differences in Focal Adhesion Kinase Expression Modulate Pulmonary Endothelial Barrier Function in Response to Inflammation / L. Ying, C.M. Alvira, D.N. Cornfield. Am. J. Physiol.-Lung Cell. Mol. Physiol., 2018, vol. 315, pp. L66–L77. https://doi.org/10.1152/ajplung.00363.2017
Zimmermann P. Why Is COVID-19 Less Severe in Children? A Review of the Proposed Mechanisms Underlying the Age-Related Difference in Severity of SARS-CoV-2 Infections / P. Zimmermann, N. Curtis. Arch. Dis. Child., 2020, vol. 106, pp. 429–439. https://doi.org/10.1136/archdischild-2020-320338
Просмотров аннотации: 99 Загрузок PDF: 62
Copyright (c) 2023 Elizaveta S. Ageeva, Natalya V. Rymarenko, Elena N. Dyadyura, Anna K. Gurtovaya, Sergey L. Safronyuk, Remzie N. Ablaeva, Svetlana V. Usova
![Лицензия Creative Commons](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.